Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Kelly E. Dooley; Debra Hanna; Vidya Mave; Kathleen Eisenach; Radojka M. Savic

doi:10.1371/journal.pmed.1002842

Loading metrics

Open Access

Collection Review articles synthesize in narrative form the best available evidence on a topic. Submission of Collection Review articles is by invitation only, and they are only published as part of a PLOS Collection as agreed in advance by the PLOS Medicine Editors.

See all article types »

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Kelly E. Dooley ,

* E-mail: kdooley1@jhmi.edu

Affiliation Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-9013-5256

⨯
Debra Hanna,

Affiliation Bill & Melinda Gates Foundation, Seattle, Washington, United States of America
⨯
Vidya Mave,

Affiliations Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Byramjee Jeejeebhoy Government Medical College–Johns Hopkins University Clinical Research Site, Pune, India

http://orcid.org/0000-0001-8509-4517

⨯
Kathleen Eisenach,

Affiliation TB or NOT TB Consulting, LLC, Little Rock, Arkansas, United States of America

http://orcid.org/0000-0002-5426-0970

⨯
Radojka M. Savic

Affiliation University of California San Francisco, San Francisco, California, United States of America
⨯

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Kelly E. Dooley,
Debra Hanna,
Vidya Mave,
Kathleen Eisenach,
Radojka M. Savic

Published: July 5, 2019
https://doi.org/10.1371/journal.pmed.1002842

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Clinical pharmacology
Is the Subject Area "Clinical pharmacology" applicable to this article?

Thanks for your feedback.
Phase III clinical investigation
Is the Subject Area "Phase III clinical investigation" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Pharmacology
Is the Subject Area "Pharmacology" applicable to this article?

Thanks for your feedback.